The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Putilova T.A.

Ural Research Institute of Maternity and Infancy

Putilova N.V.

Ural Scientific Research Institute of Maternity and Child Care

Tretyakova T.B.

Ural Research Institute of Maternity and Infancy

Ultrasound differential diagnostic criteria for antenatal diabetic fetopathy and hemolytic disease

Authors:

Putilova T.A., Putilova N.V., Tretyakova T.B.

More about the authors

Read: 1398 times


To cite this article:

Putilova TA, Putilova NV, Tretyakova TB. Ultrasound differential diagnostic criteria for antenatal diabetic fetopathy and hemolytic disease. Russian Bulletin of Obstetrician-Gynecologist. 2021;21(3):31‑36. (In Russ.)
https://doi.org/10.17116/rosakush20212103131

Recommended articles:
Modern aspe­cts of gestational diabetes mellitus: defi­nition, risk factors. Russian Bulletin of Obstetrician-Gynecologist. 2025;(2):35-41
Diaphragmatic rela­xation masquerading as COPD. Piro­gov Russian Journal of Surgery. 2025;(10-2):107-113

References:

  1. International Diabetes Federation. IDF Diabetes Atlas. 9th ed. Brussels, Belgium: International Diabetes Federation; 2019.
  2. Deryabina EG. Old and new concepts of gestational diabetes mellitus, impact on prevalence and perinatal outcomes. In the book: Diabetes Mellitus — Pandemic XXI. Collection of abstracts VIII (XXV) All-Russian Diabetological Congress with international participation. FSBI NMITs Endocrinology of the Ministry of Health of Russia; NGO «Russian Association of Endocrinologists». Moscow. 2018;398. (In Russ.).
  3. Ordynskii VF. Sonographic signs of diabetic fetopathy. Akusherstvo i ginekologiya. 2010;5-6:24-29. (In Russ.).
  4. Chamberlain C, McNamara B, Williams ED, Yore D, Oldenburg B, Oats J, Eades S. Diabetes in pregnancy among indigenous women in Australia, Canada, New Zealand and the United States: a systematic review of the evidence for screening in early pregnancy. Diab Metabol Res Rev. 2013;29:4:241-256.  https://doi.org/10.1002/dmrr.2389
  5. Burumkulova FF, Petrukhin VA, Tishenina RC, Kovalenko TS, Gur’eva VM, Troitskaya MV, Kotov YuB, Sidorova AA. Obstetric and perinatal complications in gestational diabetes mellitus. Zurnal akusherstva i zhenskikh boleznei. 2011;60:3:69-73. (In Russ.).
  6. Antonov AG, Degtyarev DN, Narogan MV, Karpova AL, Sen’kevich OA, Safarov AA, Son ED, Malyutina LV. Hemolytic disease of newborns. In: Neonatology. Clinical recommendations. Ed. by Volodin N.N., Degtyarev D.N., Kryuchko D.S. Moscow: GEOTAR-Media; 2019;19-35. (In Russ.).
  7. Clinical guidelines (protocol) «Rh-sensitization. Hemolytic disease of the fetus», developed in accordance with Article 76 of the Federal Law of November 21, 2011. №323-FZ «On the basics of health protection of citizens in the Russian Federation». Letter dated 05/18/2017 No. 15-4/10/2-3300.
  8. Antenatal ultrasonic diagnosis of diabetic fetopathy and macrosomia. Informational methodical letter. Ed. Krasnopol’skii V.I. Moscow: Max Press; 2013;22. (In Russ.).
  9. Lysenko SN, Chechneva MA, Petrukhin VA, Burumkulova FF, Ermakova LB. Ultrasound diagnosis of diabetic fetopathy. Rossiiskii vestnik akushera-ginekologa. 2016;16:3:23-30. (In Russ.). https://doi.org/10.17116/rosakush201616323-30
  10. Santos MJ, Fernandes V, Margues O. Effect of maternal body mass index and weight gain in women with gestational diabetes on the incidence of large-for-gestational-age infants. Diabetes Metab. 2016;42:6:471-474.  https://doi.org/10.1016/j.diabet.2016.06.008
  11. Kamana KC, Sumisti S, Hua Z. Gestational diabetes mellitus and macrosomia: a literature review. Ann Nutr Metab. 2015;66:2:14-20.  https://doi.org/10.1159/000371628
  12. Catalano PM, Hauguel-De Mouzon S. Is it time to revisit the Pedersen hypothesis in the face of the obesity epidemic? Am J Obstet Gynecol. 2011;204:479-487.  https://doi.org/10.1016/j.ajog.2010.11.039
  13. William L. Lowe Jr., Scholtens DM, Kuang A, Linder B, Lawrence JM, Lebenthal Ya, McCance D, Hamilton J, Nodzenski M, Talbot O, Brickman WJ, Clayton P, Ma RC, Tam WH, Dyer AR, Catalano PM, Lowe LP and Metzger BE, on behalf of the HAPO Follow-up Study Cooperative Research Group. Hyperglycemia and Adverse Pregnancy Outcome Follow-up Study (HAPO FUS): Maternal gestational diabetes mellitus and childhood glucose metabolism. Diabetes Care. 2019;42:3:372-380.  https://doi.org/10.2337/dc18-1646
  14. Farrar D, Simmonds M, Bryant M, Sheldon TA, Tuffnell D, Golder S, Dunne F, Lawlor DA. Hyperglycaemia and risk of adverse perinatal outcomes: systematic review and meta-analysis. BMJ. 2016;354:i4694. https://doi.org/10.1136/bmj.i4694
  15. Krasnopol`skii VI, Petrukhin VA, Chechneva MA, Lysenko S.N., Ermakova L.B. Antenatal ultrasonic diagnosis of diabetic fetopathy and macrosomia. Arkhiv akusherstva i ginekologii im. V.F. Snegireva. 2014;1:51-53. (In Russ.).
  16. Garcia—Flores J, Cruceyra M, Canamares M. Predictive value of fetal hepatic biometry for birth weight and cord blood markers in gestational diabetes. J Perinatol. 2016;36:9:723-728.  https://doi.org/10.1038/jp.2016.72
  17. Ordynskii VF. Ultrasound in pregnant women with diabetes mellitus. Vestnik Rossiiskogo gosudarstvennogo meditsinskogo universiteta. 2009;4:87-90. (In Russ.).
  18. Burumkulova FF, Petrukhin VA, Lysenko SN, Chechneva MA, Kovalenko TS, Kotov YuB. Early ultrasound prediction of development of fetal macrosomia in pregnant women with gestational diabetes mellitus. Rossiiskii vestnik akushera-ginekologa. 2011;11:5:4-7. (In Russ.).
  19. Lee BH, Park TCh, Lee HJ. Association between fetal abdominal circumference and birthweight in maternal hyperglycemia. Asta Obstet Gynecol Scand. 2014;93:8:786-793.  https://doi.org/10.1111/aogs.12420
  20. Dedov II, Krasnopol’skii VI, Sukhikh GT, on behalf of the working group. Russian consensus «Gestational diabetes diagnosis treatment post — natal support». Saharnyi diabet. 2012;2:2-6. (In Russ.).
  21. Gonzales AB, Young L, Doll JA. Elevated neonatal insulin-like growth factor I is associated with fetal hypertrophic cardiomyopathy in diabetic women. Am J Obstets Gynecol. 2014;211:3:290.  https://doi.org/10.1016/j.ajog.2014.05.011
  22. Paauw ND, Stegeman R, de Vroede MAMJ. Neonatal cardiac hypertrophy the role of hyperinsulinism — a review of literature. Eur J Pediatr. 2019;179:1:39-50.  https://doi.org/10.1007/s00431-019-03521-6
  23. Belovedenko MA, Zenkova EV. Hyperglycemia effect on fetus in gestational and manifest type 2 diabetes mellitus. Sibirskii meditsinskii zurnal. 2018;2:34-42. (In Russ.).
  24. Warska A, Maliszewska A, Wnuk A. Current knowledge on the use of ultrasound measurement of fetal soft tissues for the assessment of pregnancy development. J Ultrason. 2018;72:18:50-55.  https://doi.org/10.15557/JoU.2018.0008
  25. Buhling KJ, Doll I, Siebert G. Relationship between sonographically estimated fetal subcutaneous adipose tissue measurements and neonatal skinfold measurements. Ultrasound Obstet Gynecol. 2012;39:5:558-562.  https://doi.org/10.1002/uog.10092
  26. Maruotti GM, Saccone G, Martinelli P. Third trimester ultrasound soft — tissue measurement accurately predicts macrosomia. J Matern Fetal Neonatal Med. 2017;30:8:972-976.  https://doi.org/10.1080/14767058.2016.1193144
  27. Lee SM, Jun JK, Lee EJ. Measurement of fetal urine production to differentiate causes of increased amniotic fluid volume. Ultrasound Obstet Gynecol. 2010;36:2:191-195.  https://doi.org/10.1002/uog.7519
  28. Dodkhoeva MF, Pirmatova DA. Gestational diabetes mellitus a modern view on the actual problem. Vestnic Avitsenny. 2018;20:4:455-461. (In Russ.). https://doi.org/10.25005/2074-0581-2018-20-4-455-461
  29. Epishkina-Minina AA, Khamoshina MB, Grabovsky VM. Gestational diabetes mellitus: current state of the problem Akusherstvo i ginekologiya: Nowosti. Mneniya. Obucheniya. 2018;6:3:23-29. (In Russ.). https://doi.org/10.24411/2303-9698-2018-13903
  30. Dębska M, Kretowicz P, Tarasiuk A, Dangel J. Successful intrauterine triatment and gool long —term outcome in an extremely severe case of fetal hemolytic disease. J Ultrason. 2014;14:57:217-222.  https://doi.org/10.15557/JoU.2014.0021
  31. Safonova IN. Antenatal echographic monitoring in fetal haemolytic disease. SonoAce Ultrasound. 2016;29:1-26. (In Russ.).
  32. Sheibak LN. Modern ideas about the features of haemolytic disease of the fetus and newborn. Zurnal Grodnenskogo gosudarstvennogo meditsinskogo universiteta. 2015;1:134-138. (In Russ.).
  33. Cabral AC, Reis ZS, Apocalypse IG. Combined use of the cardiofemoral index and middle cerebral artery Doppler velocimetry for the prediction of fetal anemia. Int J Gynaecol Obstet. 2010;111:3:205-208.  https://doi.org/10.1016/j.ijgo.2010.07.017
  34. Peixoto-Filho FM, Rodrigues JF, Sá CA. Reassessing the value of cardiofemoral index in the management of Rh(D) alloimmunized pregnancies: a pilot study. Eur J Obstet Gynecol Reprod Biol. 2011;159:1:242-243.  https://doi.org/10.1016/j.ejogrb.2011.07.021
  35. Bystrykh OA, Balashova EN, Fedorova TA. Correction of fetal anemia of a fetus with hemolytic disease by intrauterine blood transfusion: Effectiveness and outcomes in newborns. Vestnik sluzhby krovi Rossii. 2016;4:5-10. (In Russ.).
  36. Prefumo F, Fichera A, Fratelli N. Fetal anemia: Diagnosis and management. Best Pract Res Clin Obstet Gynaecol. 2019;58:2-14.  https://doi.org/10.1016/j.bpobgyn.2019.01.001
  37. Garabedian C, Vaast P, Behal H. Management of severe fetal anemia by Doppler measurement of middle cerebral artery: are the other benefits than reducing invasive procedures? Eur J Obstet Gynecol Reprod Biol. 2015;192:27-30.  https://doi.org/10.1016/j.ejogrb.2015.06.016
  38. Babovic I, Plesinas S, Radojicic Z. Middle cerebral artery Doppler in prediction degree of fetal anemia and the best timing for the second intrauterine intravascular transfusion in red cell alloimmune disease. Clin Exp Obstet and Gynecol. 2015;42:6:792-796. 
  39. Kumar M, Umrawal T, Singh A. Middle cerebral artery Doppler reference centile charts for the prediction of fetal anemia in a population from India. Int J Gynaecol Obstet. 2017;139:3:307-311.  https://doi.org/10.1002/ijgo.12318
  40. Markov D, Pavlova E, Atanassova D. The fetal Middle Cerebral artery peak systolic velocity as a predictor of fetal anemia in RH-alloimmunized pregnancy. Akush Ginekol (Sofiya). 2015;54:4:67-72. 
  41. Martinez—Portilla RJ, Lopez-Felix J, Hawkins-Villareal A. Performance of fetal middle cerebral artery peak systolic velocity for prediction of anemia in untransfused and transfused fetuses: systematic review and meta-analysis. Ultrasound Obstet Gynecol. 2019;54:6:722-731.  https://doi.org/10.1002/uog.20273
  42. Brennand J. Middle cerebral artery Doppler. Austral J Ultrasound Med. 2009;12:3:35-38. 
  43. Isakhanov MA, Sharipova MG, Manabaeva GK. Prevention and non-invasive diagnosis of fetal hemolytic disease. Universum: Meditsina i farmakologiya: electron. scientific. journal. 2019;4(59). (In Russ.). https://7universum.com/ru/med/archive/item/7477.
  44. Kravchenko EN, Ozherelyeva MA., Kuklina L.V. A noninvasive method for the prediction of fetal hemolytic disease. Rossiiskii vestnik perinatologii i pediatrii. 2017;62:2:39-44. (In Russ.). https://doi.org/10.21508/1027-4065-2017-62-2-39-44
  45. Dantas Andrea MA, Palmieri Andrea BS, Vieira MR. Doppler ultrasonographic assessment of fetal middle cerebral artery peak systolic velocity in gestational diabetes mellitus. Int J Gynaecol Obstet. 2019;144:2:174-179.  https://doi.org/10.1002/ijgo.12723
  46. Fasano RM. Haemolytic Disease of the Fetus and Newborn in the molecular era. Semin Fetal Neonatal Med. 2016;21:1:28-34.  https://doi.org/10.1016/j.siny.2015.10.006
  47. Sørensen K, Kjeldsen-Kragh J, Husby H. Determination of fetal RHD type in plasma of RhD negative pregnant women. Scand J Clin Lab Invest. 2018;78:5:411-416.  https://doi.org/10.1080/00365513.2018.1475681

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.